Quantitative Micro-miniature Intrapartum Monitor in neonates

Overview

About this study

The purpose of this study is to determine whether the sensing and transmitting capabilities housed in the Quantitative Micro-miniature Intrapartum Monitor (QMIM), which previously have been studied in adult humans and fetal sheep, can be replicated in human neonates.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

six patients ≥ week old and six patients ≥ 1 and < 12 hours old

Exclusion Criteria:

known or suspected major anomalies
known or suspected skin injury (i.e. skin breakdown attributed to injury during the process of delivery)
patients currently receiving clinical care that is supervised by the Principal Investigator (William A. Carey, MD)

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/25/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator William Carey, M.D.	Open for enrollment	Contact information: William Carey M.D. (507) 266-9397 Carey.William@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

William Carey, M.D.

Open for enrollment

Contact information:

William Carey M.D.

(507) 266-9397

Carey.William@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials